Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit.

Authors:
Eleni Frangou
Eleni Frangou
General Hospital of Athens
Greece
Jane Holmes
Jane Holmes
University of Wales College of Medicine
Sharon Love
Sharon Love
St Thomas's Hospital
United Kingdom
Maria Hawkins
Maria Hawkins
Princess Margaret Hospital
Canada

Trials 2017 Dec 28;18(1):620. Epub 2017 Dec 28.

CRUK MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK.

Background: For a clinical trials unit to run its first model-based, phase I trial, the statistician, chief investigator, and trial manager must all acquire a new set of skills. These trials also require a different approach to funding and data collection.

Challenges And Discussion: From the statisticians' viewpoint, we highlight what is needed to move from running rule-based, early-phase trials to running a model-based phase I study as we experienced it in our trials unit located in the United Kingdom. Our example is CHARIOT, a dose-finding trial using the time-to-event continual reassessment method. It consists of three stages and aims to discover the maximum tolerated dose of the combination of radiotherapy, chemotherapy, and the ataxia telangiectasia mutated Rad3-related inhibitor M6620 (previously known as VX-970) in patients with oesophageal cancer. We present the challenges we faced in designing this trial and how we overcame them as a way of demystifying the conduct of a model-based trial in a grant-funded clinical trials unit.

Conclusions: Although we appreciate that undertaking model-based trials requires additional time and effort, they are feasible to implement and, once suitable tools such as guiding publications and document templates become available, the design and set-up process will be easier and more efficient.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-017-2389-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746014PMC

Still can't find the full text of the article?

Sign up to send a request to the authors directly.
December 2017
8 Reads

Publication Analysis

Top Keywords

clinical trials
12
trials unit
12
model-based phase
12
grant-funded clinical
8
trials
7
model-based
5
trial
5
continual reassessment
4
requires additional
4
trial time-to-event
4
time-to-event continual
4
additional time
4
reassessment method
4
model-based trials
4
stages aims
4
undertaking model-based
4
three stages
4
consists three
4
trials requires
4
method consists
4

References

(Supplied by CrossRef)
Article in Biometrics
YK Cheung et al.
Biometrics 2000
Article in Br J Cancer
SB Love et al.
Br J Cancer 2017

R Hemmings et al.
2006
Article in J Pharmacokinet Pharmacodyn
EMJ Brummelen van et al.
J Pharmacokinet Pharmacodyn 2016
Article in Br J Cancer
V Levy et al.
Br J Cancer 2006
Article in BMC Med Res Methodol
U Lorch et al.
BMC Med Res Methodol 2014
Article in Eur J Cancer
X Paoletti et al.
Eur J Cancer 2006
Article in Stat Med
GR Petroni et al.
Stat Med 2017
Article in BMC Med Res Methodol
K Brock et al.
BMC Med Res Methodol 2017
Article in Clin Cancer Res
C Yap et al.
Clin Cancer Res 2017

Similar Publications

Social Relations at Work and Incident Dementia: 29-Years' Follow-Up of the Copenhagen Male Study.

J Occup Environ Med 2018 Jan;60(1):12-18

Department of Public Health (Mr Ishtiak-Ahmed, Dr Hansen, Dr Garde, Mr Mortensen, Dr Lund, Dr Rod, Dr Westendorp, Dr Nabe-Nielsen); Center for Healthy Aging (Mr Mortensen, Dr Lund, Dr Westendorp); Department of Cardiology, Bispebjerg Hospital (Dr Prescott); Danish Dementia Research Centre, Rigshospitalet (Dr Phung, Dr Waldemar), University of Copenhagen; and The National Research Centre for the Working Environment (Dr Hansen, Dr Garde, Dr Gyntelberg), Copenhagen, Denmark.

Objective: We investigated whether social relations at work were associated with incident dementia in old age.

Methods: One thousand five hundred seventy-two occupationally active men from the Copenhagen Male Study Cohort were followed from 1986 to 2014. Participants underwent a clinical examination at baseline and answered questionnaires on whether they (1) had possibilities to be in contact with coworkers, (2) could get along with coworkers, and (3) were satisfied with supervisor. Read More

View Article
January 2018
9 Reads
1.80 Impact Factor

Conservation of the Nrf2-Mediated Gene Regulation of Proteasome Subunits and Glucose Metabolism in Zebrafish.

Oxid Med Cell Longev 2016 27;2016:5720574. Epub 2016 Dec 27.

Department of Molecular and Developmental Biology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.

The Keap1-Nrf2 system is an evolutionarily conserved defense mechanism against oxidative and xenobiotic stress. Besides the exogenous stress response, Nrf2 has been found to regulate numerous cellular functions, including protein turnover and glucose metabolism; however, the evolutionary origins of these functions remain unknown. In the present study, we searched for novel target genes associated with the zebrafish Nrf2 to answer this question. Read More

View Article
March 2017
5 Reads
2 PubMed Central Citations(source)

Accelerometers for objective evaluation of physical activity following spine surgery.

J Clin Neurosci 2016 Apr 4;26:14-8. Epub 2016 Jan 4.

NeuroSpine Surgery Research Group (NSURG), Sydney, NSW, Australia; NeuroSpine Clinic, Prince of Wales Private Hospital, Suite 7, Level 7, Randwick, Sydney, NSW 2031, Australia; University of New South Wales (UNSW) Australia, Sydney, NSW, Australia. Electronic address:

With the potential of bias from subjective evaluation scores in spine surgery, there is a need for practical and accurate quantitative methods of analysing patient recovery. In recent years, technologies such as accelerometers and global positioning systems have been introduced as potential objective measures for pain and symptoms following spine surgery. Overall, this perspective article aims to discuss and critique currently utilised methods of monitoring spine surgical outcomes. Read More

View Article
April 2016
25 Reads
1 PubMed Central Citation(source)
1.32 Impact Factor

Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study.

Clin Transl Med 2015 23;4:17. Epub 2015 Apr 23.

Laboratory for Molecular Medicine and Metabolism, Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon ; Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon ; National Obesity Center, Yaoundé Central Hospital, Yaoundé, Cameroon.

Background: To study the relationship between the rs12255372 (G/T) polymorphism of the transcription factor 7-like 2 (TCF7L2) and type 2 diabetes mellitus (T2DM) in a Cameroonian population.

Methods: This case-control study included 60 T2DM patients and 60 healthy normoglycemic controls, all unrelated and of Cameroonian origin, aged above 40 years (range 40-87). The Restriction Fragment Length Polymorphism - Polymerase Chain Reaction (RFLP-PCR) was used for genotyping. Read More

View Article
May 2015
22 Reads
4 PubMed Central Citations(source)

Nonadherence and contributing factors among ambulatory patients with antidiabetic medications in Adama Referral Hospital.

J Diabetes Res 2014 3;2014:617041. Epub 2014 Dec 3.

Department of Pharmacy, College of Medicine and Health Science, Ambo University, Oromia Region, Ethiopia.

Unlabelled: The objective of this study was to determine the magnitude of nonadherence and its contributing factors among diabetic patients attending the diabetic clinic in Adama Hospital.

Methods: This descriptive cross-sectional study was carried out among patients with diabetes mellitus attending the diabetes mellitus clinic of Adama Referral Hospital. Every other patient was selected and data regarding their medication adherence was collected using a structured interview. Read More

View Article
July 2015
4 Reads
6 PubMed Central Citations(source)